Shenzhen Kangtai Biological Products Co., Ltd.
SZSE:300601.SZ
28.75 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 1,195.582 | 1,017.622 | 3,549.514 | 882.693 | 505.219 | 634.609 | 159.748 | 110.884 | 149.519 | 221.665 | 76.434 | 216.106 |
| Short Term Investments
| 563.355 | 440.828 | 725.57 | 2,155.143 | 0 | 0 | 100 | 26.8 | 20 | 11 | 14.5 | 0 |
| Cash and Short Term Investments
| 1,758.938 | 1,458.45 | 3,549.514 | 3,037.837 | 505.219 | 634.609 | 159.748 | 110.884 | 149.519 | 221.665 | 76.434 | 216.106 |
| Net Receivables
| 2,819.227 | 2,414.721 | 1,991.238 | 1,765.74 | 1,070.622 | 909.395 | 549.098 | 301.029 | 173.171 | 163.388 | 146.008 | 102.173 |
| Inventory
| 772.854 | 727.799 | 1,058.194 | 436.545 | 228.76 | 196.087 | 180.834 | 141.097 | 110.843 | 148.929 | 140.549 | 135.956 |
| Other Current Assets
| 44.985 | 573.88 | 741.744 | 104.447 | 23.595 | 0.141 | 100 | 26.8 | 27.639 | 14.904 | 16.812 | 2.751 |
| Total Current Assets
| 5,396.004 | 5,174.85 | 7,340.69 | 5,344.57 | 1,828.195 | 1,740.232 | 989.68 | 579.81 | 461.173 | 548.886 | 379.802 | 456.986 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 5,756.872 | 5,176.125 | 4,116.402 | 2,279.063 | 1,367.235 | 1,166.296 | 853.254 | 752.087 | 599.15 | 538.446 | 474.826 | 395.924 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 504.238 | 475.163 | 736.264 | 367.354 | 365.192 | 204.207 | 215.822 | 191.294 | 177.944 | 171.402 | 163.241 | 221.837 |
| Goodwill and Intangible Assets
| 504.238 | 475.163 | 736.264 | 367.354 | 365.192 | 204.207 | 215.822 | 191.294 | 177.944 | 171.402 | 163.241 | 221.837 |
| Long Term Investments
| 2,696.246 | 2,041.325 | 99.425 | 122.632 | 86.212 | 30.04 | 16.6 | 6.653 | 8.944 | 11.557 | 11.419 | 9.596 |
| Tax Assets
| 630.317 | 708.319 | 558.603 | 702.048 | 271.781 | 161.484 | 84.116 | 50.745 | 35.523 | 32.275 | 35.581 | 28.061 |
| Other Non-Current Assets
| 101.681 | 210.569 | 1,297.602 | 768.842 | 33.793 | 34.186 | 51.239 | 20.311 | 51.093 | 39.5 | 42.034 | 24.311 |
| Total Non-Current Assets
| 9,689.355 | 8,611.502 | 6,808.295 | 4,239.938 | 2,124.213 | 1,596.214 | 1,221.032 | 1,021.089 | 872.654 | 793.18 | 727.102 | 679.729 |
| Total Assets
| 15,085.359 | 13,786.352 | 14,148.985 | 9,584.508 | 3,952.408 | 3,336.446 | 2,210.711 | 1,600.899 | 1,333.826 | 1,342.066 | 1,106.904 | 1,136.715 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 791.177 | 434.132 | 708.196 | 167.361 | 116.571 | 98.419 | 60.559 | 35.873 | 38.294 | 39.931 | 40.952 | 21.076 |
| Short Term Debt
| 174.338 | 273.683 | 800.133 | 23.39 | 61 | 49.136 | 65.93 | 67.856 | 76.212 | 190.54 | 118.228 | 38.2 |
| Tax Payables
| 25.864 | 173.371 | 98.152 | 678.468 | 8.437 | 22.365 | 41.574 | 9.104 | 6.973 | 1.298 | 1.001 | 0.988 |
| Deferred Revenue
| 28.756 | 31.227 | 1,106.981 | 1,565.161 | 658.671 | 22.365 | 602.967 | 250.074 | 141.716 | 87.468 | 84.324 | 86.484 |
| Other Current Liabilities
| 1,757.08 | 1,600.77 | 2.824 | 0.031 | 33.938 | 804.105 | 47.025 | 55.536 | 58.714 | 27.237 | 21.386 | 15.857 |
| Total Current Liabilities
| 2,751.351 | 2,339.812 | 2,618.135 | 1,755.942 | 870.179 | 974.024 | 776.481 | 409.339 | 314.936 | 345.176 | 264.89 | 161.617 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 2,372.216 | 2,015.68 | 1,937.971 | 67.795 | 195.018 | 412.639 | 227.433 | 281.364 | 187.865 | 272.108 | 375.333 | 446.7 |
| Deferred Revenue Non-Current
| 328.702 | 383.103 | 349.541 | 278.5 | 122.315 | 89.435 | 108.284 | 145.012 | 155.44 | 95.423 | 65.08 | 67.214 |
| Deferred Tax Liabilities Non-Current
| 26.891 | 26.084 | 41.471 | 18.834 | 10.662 | 1.814 | 1.76 | 2.243 | 2.726 | 3.209 | 3.693 | 4.231 |
| Other Non-Current Liabilities
| -264.188 | 36.334 | 35.131 | 0 | 0 | 25.742 | 25.742 | 27.942 | 25.742 | 42.338 | 25.742 | 25.742 |
| Total Non-Current Liabilities
| 2,463.621 | 2,461.202 | 2,364.115 | 365.129 | 327.996 | 529.63 | 363.218 | 456.561 | 371.774 | 413.078 | 469.848 | 543.887 |
| Total Liabilities
| 5,214.971 | 4,801.014 | 4,982.249 | 2,121.072 | 1,198.175 | 1,503.654 | 1,139.699 | 865.901 | 686.709 | 758.254 | 734.738 | 705.504 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 95.64 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1,116.917 | 1,120.494 | 687.094 | 684.927 | 645.221 | 638.552 | 421.142 | 369 | 369 | 369 | 357 | 357 |
| Retained Earnings
| 2,216.688 | 1,641.088 | 2,435.007 | 1,397.944 | 990.175 | 616.717 | 349.694 | 168.722 | 82.508 | 19.687 | -11.476 | 48.106 |
| Accumulated Other Comprehensive Income/Loss
| 3,117.449 | 3,036.025 | 2,417.491 | 1,753.574 | 450.034 | 61.746 | -95.64 | 1.184 | 195.609 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 3,090.631 | 3,187.732 | 3,627.143 | 3,626.992 | 668.803 | 515.777 | 300.176 | 196.092 | 0 | 195.125 | 26.642 | 26.104 |
| Total Shareholders Equity
| 9,541.685 | 8,985.338 | 9,166.736 | 7,463.436 | 2,754.233 | 1,832.792 | 1,071.012 | 734.998 | 647.117 | 583.812 | 372.166 | 431.21 |
| Total Equity
| 9,541.685 | 8,985.338 | 9,166.736 | 7,463.436 | 2,754.233 | 1,832.792 | 1,071.012 | 734.998 | 647.117 | 583.812 | 372.166 | 431.21 |
| Total Liabilities & Shareholders Equity
| 15,085.359 | 13,786.352 | 14,148.985 | 9,584.508 | 3,952.408 | 3,336.446 | 2,210.711 | 1,600.899 | 1,333.826 | 1,342.066 | 1,106.904 | 1,136.715 |